Aarhus Universitets segl

SARS-CoV-2 suppresses IFNβ production mediated by NSP1, 5, 6, 15, ORF6 and ORF7b but does not suppress the effects of added interferon

Publikation: Bidrag til tidsskrift/Konferencebidrag i tidsskrift /Bidrag til avisTidsskriftartikelForskningpeer review

  • Maya Shemesh, Weizmann Institute of Science
  • ,
  • Turgut E. Aktepe, University of Melbourne
  • ,
  • Joshua M. Deerain, University of Melbourne
  • ,
  • Julie L. McAuley, University of Melbourne
  • ,
  • Michelle D. Audsley, Monash University
  • ,
  • Cassandra T. David, Monash University
  • ,
  • Damian F.J. Purcell, University of Melbourne
  • ,
  • Victoria Urin, Weizmann Institute of Science
  • ,
  • Rune Hartmann
  • Gregory W. Moseley, Monash University
  • ,
  • Jason M. Mackenzie, University of Melbourne
  • ,
  • Gideon Schreiber, Weizmann Institute of Science
  • ,
  • Daniel Harari, Weizmann Institute of Science

Type I Interferons (IFN-Is) are a family of cytokines which play a major role in inhibiting viral infection. Resultantly, many viruses have evolved mechanisms in which to evade the IFN-I response. Here we tested the impact of expression of 27 different SARS-CoV-2 genes in relation to their effect on IFN production and activity using three independent experimental methods. We identified six gene products; NSP6, ORF6, ORF7b, NSP1, NSP5 and NSP15, which strongly (>10-fold) blocked MAVS-induced (but not TRIF-induced) IFNβ production. Expression of the first three of these SARS-CoV-2 genes specifically blocked MAVSinduced IFNβ-promoter activity, whereas all six genes induced a collapse in IFNβ mRNA levels, corresponding with suppressed IFNβ protein secretion. Five of these six genes furthermore suppressed MAVS-induced activation of IFNλs, however with no effect on IFNα or IFNγ production. In sharp contrast, SARS-CoV-2 infected cells remained extremely sensitive to anti-viral activity exerted by added IFN-Is. None of the SARS-CoV-2 genes were able to block IFN-I signaling, as demonstrated by robust activation of Interferon Stimulated Genes (ISGs) by added interferon. This, despite the reduced levels of STAT1 and phospho- STAT1, was likely caused by broad translation inhibition mediated by NSP1. Finally, we found that a truncated ORF7b variant that has arisen from a mutant SARS-CoV-2 strain harboring a 382-nucleotide deletion associating with mild disease (Δ382 strain identified in Singapore & Taiwan in 2020) lost its ability to suppress type I and type III IFN production. In summary, our findings support a multi-gene process in which SARS-CoV-2 blocks IFN-production, with ORF7b as a major player, presumably facilitating evasion of host detection during early infection. However, SARS-CoV-2 fails to suppress IFN-I signaling thus providing an opportunity to exploit IFN-Is as potential therapeutic antiviral drugs.

OriginalsprogEngelsk
Artikelnummere1009800
TidsskriftPLOS Pathogens
Vol/bind17
Nummer8
Antal sider31
ISSN1553-7366
DOI
StatusUdgivet - aug. 2021

Se relationer på Aarhus Universitet Citationsformater

ID: 223673456